SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SI-BONE, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$19.66−0.02 (-0.10%)
Close on Oct 19, 2026
- Market cap
- $874.42M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
SI-BONE, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $202.35M | $195.55M | $191.08M | $184.54M | $176.44M | $167.83M | $158.42M | $148.16M | $142.19M | $135.59M | $130.62M | $123.95M | 94.7% | +14.7% |
| International | $11.25M | $10.68M | $9.85M | $9.04M | $8.82M | $8.78M | $8.76M | $8.88M | $8.52M | $8.45M | $8.27M | $8.03M | 5.3% | +27.5% |
From the segment and revenue-disaggregation notes of Si-Bone's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.